1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,590 | 0,598 | 12:01 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Theraclion Reports Major Recent Developments and Announces Its 2025 Half-Year Financial Results | 239 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose... ► Artikel lesen | |
| 21.10. | Theraclion Secures Key Chinese Certification, Advancing Toward Market Access in China | 212 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein®, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose... ► Artikel lesen | |
| 10.10. | Theraclion: Monthly Information on the Total Number of Voting Rights and Shares Comprising the Share Capital | 301 | Business Wire | Article 223-16 du Règlement Général de l'Autorité des marchés financiers
Regulatory News:
Theraclion (Paris:ALTHE):
Place de cotation: Euronext Growth Paris
Éligible PEA PME
Code ISIN:... ► Artikel lesen | |
| 24.09. | Theraclion: Sonovein Receives MDR Certification, Strengthening Its Commercial Potential | 258 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein®, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose... ► Artikel lesen | |
| 15.09. | Theraclion Announces Successful U.S. FDA Pivotal Study With 96.8% Occlusion Rate | 234 | Business Wire | Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250915148081/en/Sonovein redefines varicose vein treatment with advanced... ► Artikel lesen | |
| 25.07. | Theraclion Growth Up in S1 2025 | 557 | Business Wire | Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250725366467/en/Sonovein®, the first and only non-invasive varicose veins... ► Artikel lesen | |
| THERACLION Aktie jetzt für 0€ handeln | |||||
| 29.04. | Theraclion Announces Financial Results 2024 and Reviews Progress | 443 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy, announces... ► Artikel lesen | |
| 26.03. | Theraclion Completes Its Previous Financing Round With an Additional Convertible Bonds Issuance | 486 | Business Wire | Issuance of warrants for bonds convertible into shares, in accordance with Theraclion's commitment, to investors who have requested them, for a maximum amount of 580,000 euros. 290,000... ► Artikel lesen | |
| 20.02. | Theraclion Secures Financing From Its Historical Shareholders Through a Convertible Bond Loan | 655 | Business Wire | Reserved issuance of warrants for convertible bonds based on a fixed price per share of 0.20 euros (without discount), for a maximum amount of €6 million, benefiting Furui and Unigestion, the... ► Artikel lesen | |
| 11.02. | Theraclion Announces Treatment of First Patients With New SONOVEIN 'SpeedPulse' Feature Accelerating Treatment | 461 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy, announces... ► Artikel lesen | |
| 07.02. | Theraclion: Publication of Adjusted Accounts for the First Half of 2024 | 560 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy for the treatment... ► Artikel lesen | |
| 06.01. | Theraclion Reviews Its 2024 Achievements | 363 | Business Wire | Regulatory News:
THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing a robotic platform for non-invasive high-intensity focused ultrasound (HIFU) therapy for the treatment... ► Artikel lesen |
12 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| GERRESHEIMER | 27,240 | -1,30 % | Gerresheimer: Weitere Details - millionenschwere Fehlbuchung | Am Wochenende hat der Spezialverpackungshersteller Gerresheimer per Ad-Hoc-Mitteilung dem Kapitalmarkt weitere Details zur laufenden Prüfung problematischer Buchungen im Konzernbericht für das Fiskaljahr... ► Artikel lesen | |
| MCKESSON | 710,00 | +0,85 % | McKesson declares $0.82 dividend | ||
| INMODE | 12,615 | -1,48 % | InMode Ltd.: InMode Reports Second Quarter 2025 Financial Results: Quarterly Revenue of $95.6 Million, 80% Gross Margins | YOKNEAM, Israel, July 30, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced... ► Artikel lesen | |
| HCA HEALTHCARE | 400,50 | +0,38 % | HCA Healthcare, Inc. - 8-K, Current Report | ||
| LIMES SCHLOSSKLINIKEN | 350,00 | +0,57 % | Limes Schlosskliniken: Ganz starkes Update | Ende August 2025 sah der Chart kurzfristig noch mal kritisch aus. Doch kurz vor der nahenden 200-Tage-Durchschnittslinie hat sich die Notiz der schon mehrfach von boersengefluester.de vorgestellten... ► Artikel lesen | |
| BEYOND AIR | 2,070 | 0,00 % | Beyond Air Signs New International LungFit PH Distribution Agreements, Most Notably in Japan | GARDEN CITY, N.Y., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" or the "Company"), a commercial-stage medical device and biopharmaceutical company focused on harnessing... ► Artikel lesen | |
| HEALTHCARE SERVICES GROUP | 15,900 | +2,58 % | HEALTHCARE SERVICES GROUP INC - 10-Q, Quarterly Report | ||
| INTERPACE BIOSCIENCES | 0,840 | 0,00 % | Interpace Biosciences, Inc.: Interpace Biosciences Presented Two New Posters at the 2025 American Thyroid Association (ATA) Annual Meeting | ||
| MODERN DENTAL | 0,600 | +2,56 % | Modern Dental Group Limited: CGSI Reiterates 'Add' Rating on Modern Dental (03600.HK) with Raised Target Price of HK$6.88 | HONG KONG, Sept 18, 2025 - (ACN Newswire) - CGSI reiterates the 'Add' rating on Modern Dental (03600.HK) with a higher target price of HK$6.88 in a recent report. According to the report, Modern Dental... ► Artikel lesen | |
| IVF HARTMANN | 142,00 | 0,00 % | IVF Hartmann bestätigt Ziele trotz anspruchsvollem Umfeld | Neuhausen am Rheinfall - Der Medizinalbedarf-Hersteller IVF Hartmann hat im ersten Halbjahr 2025 den Umsatz leicht gesteigert, unter dem Strich aber weniger verdient. Die Ziele für das Gesamtjahr gelten... ► Artikel lesen | |
| ADDUS HOMECARE | 99,50 | -4,33 % | Citizens bestätigt "Market Outperform"-Rating für Addus HomeCare | ||
| ICU MEDICAL | 103,00 | -0,96 % | What Analysts Are Saying About ICU Medical Stock | ||
| VITRUVIA MEDICAL | 0,765 | 0,00 % | EQS-Adhoc: Vitruvia Medical AG: Halbjahresergebnis per 30. Juni 2025 | EQS-Ad-hoc: Vitruvia Medical AG / Schlagwort(e): Halbjahresergebnis/Halbjahresbericht
Vitruvia Medical AG: Halbjahresergebnis per 30. Juni 2025
01.08.2025 / 08:25 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| XYLO TECHNOLOGIES | 5,070 | -1,74 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 22.08.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 22.08.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 22.08.2025ISIN NameCA1079302081 BRIACELL... ► Artikel lesen | |
| ACADIA HEALTHCARE | 18,600 | -1,59 % | KeyBanc lowers Acadia Healthcare stock price target to $35 from $55 |
Das Unternehmen THERACLION kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,566 Euro und damit +0,71 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu THERACLION finden Sie auf Wallstreet Online.